<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>heparin</title><link>http://www.unboundmedicine.com/medline/ebm/research/heparin</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>High mobility group box 1 complexed with heparin induced angiogenesis in a matrigel plug assay.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19893601/full_citation/High_mobility_group_box_1_complexed_with_heparin_induced_angiogenesis_in_a_matrigel_plug_assay_</link><description>Wake H, Mori S, Liu K, et al. <br/><span class="title">High mobility group box 1 complexed with heparin induced angiogenesis in a matrigel plug assay. [Journal Article]</span><br/><span class="source" title="Acta medica Okayama">Acta Med Okayama 2009 Oct; 63(5):249-62.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19893601/abstract/High_mobility_group_box_1_complexed_with_heparin_induced_angiogenesis_in_a_matrigel_plug_assay_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19893601/full_citation/High_mobility_group_box_1_complexed_with_heparin_induced_angiogenesis_in_a_matrigel_plug_assay_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19893601/High_mobility_group_box_1_complexed_with_heparin_induced_angiogenesis_in_a_matrigel_plug_assay_">Find Related Articles</a> </description></item><item><title>Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19893165/full_citation/Selective_Interaction_of_Lansoprazole_and_Astemizole_with_Tau_Polymers:_Potential_New_Clinical_Use_in_Diagnosis_of_Alzheimer's_Disease_</link><description>Rojo LE, Alzate-Morales J, Saavedra IN, et al. <br/><span class="title">Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of Alzheimer's disease : JAD">J Alzheimers Dis 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19893165/abstract/Selective_Interaction_of_Lansoprazole_and_Astemizole_with_Tau_Polymers:_Potential_New_Clinical_Use_in_Diagnosis_of_Alzheimer's_Disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19893165/full_citation/Selective_Interaction_of_Lansoprazole_and_Astemizole_with_Tau_Polymers:_Potential_New_Clinical_Use_in_Diagnosis_of_Alzheimer's_Disease_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19893165/Selective_Interaction_of_Lansoprazole_and_Astemizole_with_Tau_Polymers:_Potential_New_Clinical_Use_in_Diagnosis_of_Alzheimer's_Disease_">Find Related Articles</a> </description></item><item><title>UV-MALDI-TOF Mass Spectrometry Analysis of Heparin Oligosaccharides Obtained by Nitrous Acid Controlled Degradation and High Performance Anion Exchange Chromatography.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19892568/full_citation/UV_MALDI_TOF_Mass_Spectrometry_Analysis_of_Heparin_Oligosaccharides_Obtained_by_Nitrous_Acid_Controlled_Degradation_and_High_Performance_Anion_Exchange_Chromatography_</link><description>Bultel L, Landoni M, Grand E, et al. <br/><span class="title">UV-MALDI-TOF Mass Spectrometry Analysis of Heparin Oligosaccharides Obtained by Nitrous Acid Controlled Degradation and High Performance Anion Exchange Chromatography. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of the American Society for Mass Spectrometry">J Am Soc Mass Spectrom 2009 Oct 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19892568/abstract/UV_MALDI_TOF_Mass_Spectrometry_Analysis_of_Heparin_Oligosaccharides_Obtained_by_Nitrous_Acid_Controlled_Degradation_and_High_Performance_Anion_Exchange_Chromatography_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19892568/full_citation/UV_MALDI_TOF_Mass_Spectrometry_Analysis_of_Heparin_Oligosaccharides_Obtained_by_Nitrous_Acid_Controlled_Degradation_and_High_Performance_Anion_Exchange_Chromatography_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S1044-0305(09)00769-7">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19892568/UV_MALDI_TOF_Mass_Spectrometry_Analysis_of_Heparin_Oligosaccharides_Obtained_by_Nitrous_Acid_Controlled_Degradation_and_High_Performance_Anion_Exchange_Chromatography_">Find Related Articles</a> </description></item><item><title>Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19892063/full_citation/Comparison_of_safety_of_subcutaneous_enoxaparin_as_outpatient_anticoagulation_bridging_therapy_in_patients_with_a_mechanical_heart_valve_versus_patients_with_nonvalvular_atrial_fibrillation_</link><description>Bui HT, Krisnaswami A, Le CU, et al. <br/><span class="title">Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. [Journal Article]</span><br/><span class="source" title="The American journal of cardiology">Am J Cardiol 2009 Nov 15; 104(10):1429-33.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19892063/abstract/Comparison_of_safety_of_subcutaneous_enoxaparin_as_outpatient_anticoagulation_bridging_therapy_in_patients_with_a_mechanical_heart_valve_versus_patients_with_nonvalvular_atrial_fibrillation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19892063/full_citation/Comparison_of_safety_of_subcutaneous_enoxaparin_as_outpatient_anticoagulation_bridging_therapy_in_patients_with_a_mechanical_heart_valve_versus_patients_with_nonvalvular_atrial_fibrillation_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19892063/Comparison_of_safety_of_subcutaneous_enoxaparin_as_outpatient_anticoagulation_bridging_therapy_in_patients_with_a_mechanical_heart_valve_versus_patients_with_nonvalvular_atrial_fibrillation_">Find Related Articles</a> </description></item><item><title>Change in heparin manufacturing decreases unit dose potency.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19891038/full_citation/Change_in_heparin_manufacturing_decreases_unit_dose_potency_</link><description><span class="title">Change in heparin manufacturing decreases unit dose potency. [News]</span><br/><span class="source" title="American family physician">Am Fam Physician 2009 Nov 1; 80(9):913.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19891038/full_citation/Change_in_heparin_manufacturing_decreases_unit_dose_potency_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19891038/Change_in_heparin_manufacturing_decreases_unit_dose_potency_">Find Related Articles</a> </description></item><item><title>Capturing of cell culture-derived modified Vaccinia Ankara virus by ion exchange and pseudo-affinity membrane adsorbers.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19891005/full_citation/Capturing_of_cell_culture_derived_modified_Vaccinia_Ankara_virus_by_ion_exchange_and_pseudo_affinity_membrane_adsorbers_</link><description>Wolff MW, Siewert C, Lehmann S, et al. <br/><span class="title">Capturing of cell culture-derived modified Vaccinia Ankara virus by ion exchange and pseudo-affinity membrane adsorbers. [JOURNAL ARTICLE]</span><br/><span class="source" title="Biotechnology and bioengineering">Biotechnol Bioeng 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19891005/abstract/Capturing_of_cell_culture_derived_modified_Vaccinia_Ankara_virus_by_ion_exchange_and_pseudo_affinity_membrane_adsorbers_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19891005/full_citation/Capturing_of_cell_culture_derived_modified_Vaccinia_Ankara_virus_by_ion_exchange_and_pseudo_affinity_membrane_adsorbers_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19891005/Capturing_of_cell_culture_derived_modified_Vaccinia_Ankara_virus_by_ion_exchange_and_pseudo_affinity_membrane_adsorbers_">Find Related Articles</a> </description></item><item><title>Contralateral transradial approach for carotid artery stenting: A feasibility study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890939/full_citation/Contralateral_transradial_approach_for_carotid_artery_stenting:_A_feasibility_study_</link><description>Patel T, Shah S, Ranjan A, et al. <br/><span class="title">Contralateral transradial approach for carotid artery stenting: A feasibility study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions">Catheter Cardiovasc Interv 2009 May 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890939/abstract/Contralateral_transradial_approach_for_carotid_artery_stenting:_A_feasibility_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890939/full_citation/Contralateral_transradial_approach_for_carotid_artery_stenting:_A_feasibility_study_">Full Citation</a></description></item><item><title>Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890611/full_citation/Extended_prophylaxis_of_venous_thromboembolism_with_fondaparinux_in_patients_undergoing_major_orthopaedic_surgery_in_Italy:_a_cost_effectiveness_analysis_</link><description>Capri S, Ageno W, Imberti D, et al. <br/><span class="title">Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Internal and emergency medicine">Intern Emerg Med 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890611/abstract/Extended_prophylaxis_of_venous_thromboembolism_with_fondaparinux_in_patients_undergoing_major_orthopaedic_surgery_in_Italy:_a_cost_effectiveness_analysis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890611/full_citation/Extended_prophylaxis_of_venous_thromboembolism_with_fondaparinux_in_patients_undergoing_major_orthopaedic_surgery_in_Italy:_a_cost_effectiveness_analysis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19890611/Extended_prophylaxis_of_venous_thromboembolism_with_fondaparinux_in_patients_undergoing_major_orthopaedic_surgery_in_Italy:_a_cost_effectiveness_analysis_">Find Related Articles</a> </description></item><item><title>Anticoagulation experts assess practical effects of new heparin potency assay.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890076/full_citation/Anticoagulation_experts_assess_practical_effects_of_new_heparin_potency_assay_</link><description>Thompson CA <br/><span class="title">Anticoagulation experts assess practical effects of new heparin potency assay. [News]</span><br/><span class="source" title="American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists">Am J Health Syst Pharm 2009 Nov 15; 66(22):1970, 1976.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890076/full_citation/Anticoagulation_experts_assess_practical_effects_of_new_heparin_potency_assay_">Full Citation</a> | <a href="http://www.ajhp.org/cgi/pmidlookup%3fview=long%26amp;pmid=19890076">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19890076/Anticoagulation_experts_assess_practical_effects_of_new_heparin_potency_assay_">Find Related Articles</a> </description></item><item><title>Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889634/full_citation/Heparan_sulfate_2_O_sulfotransferase_is_required_for_triglyceride_rich_lipoprotein_clearance_</link><description>Stanford KI, Wang L, Castagnola J, et al. <br/><span class="title">Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of biological chemistry">J Biol Chem 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889634/abstract/Heparan_sulfate_2_O_sulfotransferase_is_required_for_triglyceride_rich_lipoprotein_clearance_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889634/full_citation/Heparan_sulfate_2_O_sulfotransferase_is_required_for_triglyceride_rich_lipoprotein_clearance_">Full Citation</a> | <a href="http://www.jbc.org/cgi/pmidlookup%3fview=long%26amp;pmid=19889634">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889634/Heparan_sulfate_2_O_sulfotransferase_is_required_for_triglyceride_rich_lipoprotein_clearance_">Find Related Articles</a> </description></item></channel></rss>